Presentations

List of Presentations

• Worldwide Uses of NAT
• Blood Banking in the 21st Century
• Transfusion Transmission of Hepatitis A Virus
• Implications of Nucleic Acid Technology (NAT) Testing for Transfusion Services
• The Threat Posed by West Nile Virus (WNV) in the U.S. to Transfusion Recipients
• Update on Transfusion Transmitted Infectious Diseases
• The Infectious Risk of Blood Transfusion: Then, Now and Beyond
• Blood Banking Tutorials
• Implementing a Nucleic Acid Technology (NAT) Lab
• Incidence of Mini-pool Hepatitis C Virus (HCV) NAT Negative, Single Unit NAT Positive Blood Donations among Serological Positives (anti-HCV)
• Follow-up of HCV RNA Positive, anti-HCV Negative Blood Donors
• Increased Peripheral Blood Progenitor Cells in Trauma Patients
• Beyond the “C” (Candidate non-A,B,C,D,E Viral Hepatitis Agents)
• Transfusion-Associated Graft-versus-Host Disease (T-A-GVHD): Diagnosis and Prevention
• Transfusion-related Acute Lung Injury (TRALI): Diagnosis and Prevention
• Appropriate Uses of Blood and Blood Components
• Hepatitis B Virus NAT Testing
• Why NAT?
• Hepatitis B Virus (HBV) – Current Risk from Transfusion
• An Update on vCJD
• Transfusion Reactions
• Risks of Transfusion from Infectious Agents
• Basic Blood Banking I: Immunohematology and Components
• Basic Blood Banking II: Transfusion Reactions and Transfusion Transmitted Infection
• Case Studies
• Leukocytes in Blood Transfusions: The Good, the Bad and the Ugly
• CMV “Safe” Blood: Is There Such a Thing?